We are the link between patients with additional needs and the pharmaceutical market in cases where commercial drug providers are not able to deliver what is required.
Through our owner’s directive, we have been commissioned to provide extemporaneous medications and stock formulations to provide patients with additional needs with access to individualized drugs.
Prescription of extemporaneous drugs and stock formulations takes place in collaboration with specialist doctors, prescribers and authorities.
When the prescription for an extemporaneous drug becomes more extensive, it is called a stock formulation. Stock formulations are mass-produced, have a longer shelf life and can be delivered faster than extemporaneous medications.
We strive to set a good example and be transparent in the context of sustainable enterprise. This is done through a continuous and open dialogue with all stakeholders, to ensure that we act in accordance with the directives and wishes presented. We are continuously working on measures that aim to reduce environmental impact and minimize its effects in the value chain.